Ad is loading...
CICAX
Price
$61.20
Change
-$0.84 (-1.35%)
Updated
Nov 15 closing price
VTSMX
Price
$141.25
Change
-$1.87 (-1.31%)
Updated
Nov 15 closing price
Ad is loading...

CICAX vs VTSMX

Header iconCICAX vs VTSMX Comparison
Open Charts CICAX vs VTSMXBanner chart's image
American Funds Invmt Co of Amer 529A
Price$61.20
Change-$0.84 (-1.35%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx I
Price$141.25
Change-$1.87 (-1.31%)
VolumeN/A
CapitalizationN/A
CICAX vs VTSMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CICAX vs. VTSMX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CICAX is a Buy and VTSMX is a StrongSell.

FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.73T vs. CICAX (153B). VTSMX (1.26) and CICAX (1.24) have matching dividends . CICAX was incepted earlier than VTSMX: CICAX (23 years) vs VTSMX (33 years). CICAX is a more actively managed with annual turnover of: 29.00 vs. VTSMX (2.00). CICAX has a lower initial minimum investment than VTSMX: CICAX (250) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 30.52 vs. CICAX (27.02). VTSMX return over 5 years is better than : 83.72 vs. CICAX (65.33).
CICAXVTSMXCICAX / VTSMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years33 years-
Gain YTD22.83122.392102%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets153B1.73T9%
Annual Yield % from dividends1.241.2698%
Returns for 1 year27.0230.5289%
Returns for 3 years18.2019.9191%
Returns for 5 years65.3383.7278%
Returns for 10 years74.02186.0740%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RMD234.743.31
+1.43%
ResMed
QNTM5.16-0.08
-1.53%
Quantum Biopharma Ltd
LNKB7.16-0.13
-1.78%
LINKBANCORP
RARE44.75-2.89
-6.07%
Ultragenyx Pharmaceutical
VIR8.01-0.63
-7.29%
Vir Biotechnology